L Weerekoon. Show Affiliations »
Abstract
Entities: Disease
Mesh: See more » AdultBlindness/epidemiologyConjunctivaContinental Population GroupsCorneaEye ManifestationsFemaleFundus OculiHumansInflammationInjectionsLeprosy/complicationsLeprosy/drug therapyMalaysiaMaleMiddle AgedRifampin/administration & dosageRifampin/therapeutic useScleraSex FactorsSulfones/therapeutic useUvea
Substances: See more » SulfonesRifampin
Year: 1972 PMID: 5010311 PMCID: PMC1208694 DOI: 10.1136/bjo.56.2.106
Source DB: PubMed Journal: Br J Ophthalmol ISSN: 0007-1161 Impact factor: 4.638